| Literature DB >> 35158722 |
Zijiao Zhao1, Lu Chen1, Maosheng Cao1, Tong Chen1, Yiqiu Huang1, Nan Wang1, Boqi Zhang1, Fangxia Li1, Kaimin Chen1, Chenfeng Yuan1, Chunjin Li1, Xu Zhou1.
Abstract
Uterine function during pregnancy is regulated mainly by progesterone (P4) and estrogen (E2). Serum P4 levels are known to fluctuate significantly over the course of pregnancy, especially during embryo implantation and labor. In this study, pregnant mice at E0.5, E4.5, E15.5, and E18.5 (n = 3/E) were used for an RNA-Seq-based analysis of mRNA and lncRNA expression. In this analysis, 1971 differentially expressed (DE) mRNAs, 493 known DE lncRNAs, and 1041 novel DE lncRNAs were found between E0.5 and E4.5 at the embryo implantation stage, while 1149 DE mRNAs, 192 known DE lncRNAs, and 218 novel DE lncRNAs were found between E15.5 and E18.5 at the labor stage. The expression level of lncRNA-MMP11 was significantly downregulated by P4 treatment on MSM cells, while lncRNA-ANKRD37 was significantly upregulated. Notably, 117 DE mRNAs, 19 known DE lncRNAs, and 31 novel DE lncRNAs were commonly expressed between the two stages, indicating that these mRNAs and lncRNAs may be directly or indirectly regulated by P4.Entities:
Keywords: P4; embryo implantation; labor; lncRNAs; mRNAs
Year: 2022 PMID: 35158722 PMCID: PMC8833358 DOI: 10.3390/ani12030399
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1Identification of P4-associated lncRNAs: (A) Windows of uterine P4 regulation throughout the whole pregnancy. (B) Effects of P4 on implantation or labor. (C) The screening process used in this study. (D) The number of DE mRNAs between the two stages; the red boxes denote upregulated mRNA numbers, while the blue boxes denote downregulated mRNA numbers. (E) The numbers of known DE lncRNAs between the two stages; the red boxes denote upregulated known lncRNA numbers, while the blue boxes denote downregulated known lncRNA numbers. (F) The numbers of novel DE lncRNAs between the two stages; the red boxes denote upregulated novel lncRNA numbers, while the blue boxes denote downregulated novel lncRNA numbers.
Figure 2The differential expression of lncRNAs between E0.5 and E4.5, and between E15.5 and E18.5: (A) Heatmap of lncRNAs between E0.5 and E4.5. (B) Heatmap of lncRNAs between E15.5 and E18.5. (C) Differential expression of lncRNAs between E0.5 and E4.5. (D) Differential expression of lncRNAs between E15.5 and E18.5.
Figure 3GO and KEGG analysis of DE lncRNAs’ target mRNAs’ expression: (A) Histogram of GO enrichment of DE lncRNAs’ target mRNAs between E0.5 and E4.5. (B) Scatterplot of GO enrichment for DE lncRNAs’ target mRNAs between E0.5 and E4.5. (C) Scatterplot of KEGG enrichment for DE lncRNAs’ target mRNAs between E0.5 and E4.5. (D) Histogram of GO enrichment of DE lncRNAs’ target mRNAs between E15.5 and E18.5. (E) Scatterplot of GO enrichment for DE lncRNAs’ target mRNAs between E15.5 and E18.5. (F) Scatterplot of KEGG enrichment for DE lncRNAs’ target mRNAs between E15.5 and E18.5.
Figure 4Venn diagram showing DE mRNA and DE lncRNA expression, and qRT-PCR results: (A) Similarities in DE mRNAs between E0.5 and E4.5, and between E15.5 and E18.5. (B) Similarities in known DE lncRNAs between E0.5 and E4.5, and between E15.5 and E18.5. (C) Similarities in novel DE lncRNAs between E0.5 and E4.5, and between E15.5 and E18.5. (D) qRT-PCR results for P4 treatment on MSM cells. ** p < 0.01. Data are presented as the mean ± SEM.